Specialized Care for Women: the Impact of Women’s Heart Centers
- 12 Downloads
Purpose of the review
Cardiovascular disease (CVD) has been and remains the leading cause of mortality in women in the United States. For decades, more women died every year of CVD compared to men. Heart centers for women (HCW) are developed in response to the need for greater patient and physician awareness of CVD in women and to conduct sex-specific research in women. Today, many HCW provide multispecialty and focused areas of cardiovascular care for women. HCW provide their female patients with expertise over the many stages of a woman’s life. And HCW partner with national organizations to advance research and education through specialized and focused care for women. The purpose of this review is to review the historical development of heart centers for women and discuss the types of care they provide for women.
Mortality rates from cardiovascular disease in women are finally reaching the levels of men after decades of focus on awareness, prevention, and evidence-based guideline-directed care for women.
Heart centers for women have evolved to provide subspecialty and comprehensive care for women that includes education and research. Heart centers for women are partnering with many other disease-based and patient advocacy organizations to provide care for all women at all stages of life. Alarmingly, there has been increasing CVD mortality in both men and women recently.
KeywordsWomen Cardiovascular disease Prevention Disparities Heart centers for women Specialized care
American Heart Association
coronary artery disease
Centers for Disease Control and Prevention
heart centers for women
menopausal hormone therapy
National Heart, Lung, and Blood Institute
spontaneous coronary artery dissection
Well-Integrated Screening and Evaluation for WOMen Across the Nation
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
References and Recommended Reading
- 1.Mosca L, Jones WK, King KB, Ouyang P, Redberg RF, Hill MN. Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States. American Heart Association Women’s Heart Disease and Stroke Campaign Task Force. Arch Fam Med. 2000;9(6):506–15.CrossRefPubMedGoogle Scholar
- 4.Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280(7):605–13.CrossRefPubMedGoogle Scholar
- 8.Disease WTNCfWwH. National directory of women’s heart center. 2001.Google Scholar
- 11.Mosca L, Hammond G, Mochari-Greenberger H, Towfighi A, Albert MA. Fifteen-year trends in awareness of heart disease in women: results of a 2012 American Heart Association national survey. Circulation 2013;127(11):1254–1263, e1-29.Google Scholar
- 13.Barnhart J, Lewis V, Houghton JL, Charney P. Physician knowledge levels and barriers to coronary risk prevention in women: survey results from the Women and Heart Disease Physician Education Initiative. Womens health issues. 2007;17:93-100.Google Scholar
- 15.Hirshberg A, Srinivas SK. Epidemiology of maternal morbidity and mortality. Seminars in Perinatology: WB Saunders; 2017.Google Scholar
- 16.Centers for Disease Control and Prevention. Reproductive health https://www.cdc.gov/reproductivehealth/maternalinfanthealth/pmss.html Published June 29, 2017 [October 22, 2017]. Available from: https://www.cdc.gov/reproductivehealth/maternalinfanthealth/pmss.html.
- 17.Collaborators GBDMM. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1775–1812.Google Scholar
- 19.Launer LJ, Hughes T, Yu B, Masaki K, Petrovitch H, Ross GW, et al. Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: perspective from the Honolulu Heart Program/Honolulu Asia Aging Study. Hypertension. 2010;55(6):1352–9.CrossRefPubMedPubMedCentralGoogle Scholar
- 22.Alzheimer’s Association 2014 Alzheimer’s disease facts and figures. Alzheimers Dement: J Alzheimer’s Assoc. 2014;10(2):e47–92.Google Scholar
- 31.World Health Organization. Social determinants of health: women and gender equality. http://www.who.int/social_determinants/themes/womenandgender/en. World Health Organization, 2017 August 3, 2017. Report No.